Evaluation of Typical Antipsychotic Augmentation with Sertraline in Reduction of Negative Symptoms in patients with Schizophrenia in Ahwaz Golestan Hospital

Vice Chancellor for Research and Technology Development-Ahwaz Jondishapur University of Medical Sci0 个研究点目标入组 30 人开始时间: 待定最近更新: 2018年2月22日

试验速览

暂无简介。

•Inclusion criteria for this study are as follows: schizophrenia - a negative score more than 15 in PANSS; no liver disease; not treated with ECT in the past six months; during illness for over one year; aged between 21 to 63 years old.
•The Exclusion criteria are: depression; mental retardation; schizoaffective disorder; bipolar disorder; a neurological disorder such as epilepsy, Parkinson's disease; a risky physical illness such as cardiac ischemia or heart failure; use of antidepressants or lithium for whatever reason; Leisure drug; drug abuse within one recent month (except nicotine and caffeine); extrapyramidal side effects; deafness or dumbness active suicidal or homicidal thoughts; pregnant or lactating women; at least 3 months have passed since the last time the use of long-acting antipsychotics; drugs with a history of hypersensitivity or serious interest in the study; the patient withdrew from the study and side effects.

发起方

Vice Chancellor for Research and Technology Development-Ahwaz Jondishapur University of Medical Sci